Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

被引:107
作者
Ayala, Julio E. [1 ]
Bracy, Deanna P. [2 ,3 ]
Malabanan, Carlo [3 ]
James, Freyja D. [2 ,3 ]
Ansari, Tasneem [3 ]
Fueger, Patrick T. [4 ]
McGuinness, Owen P. [2 ,3 ]
Wasserman, David H. [2 ,3 ]
机构
[1] Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Lake Nona, FL 32827 USA
[2] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN USA
[3] Vanderbilt Univ, Sch Med, Vanderbilt Mouse Metab Phenotyping Ctr, Nashville, TN USA
[4] Indiana Univ Sch Med, Dept Pediat & Cellular & Integrat Physiol, Indianapolis, IN 46202 USA
来源
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2011年 / 57期
关键词
Medicine; Issue; 57; Glucose; insulin; clamp; mice; insulin resistance; diabetes; liver; muscle; conscious; restraint-free; non-stressed;
D O I
10.3791/3188
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Type 2 diabetes is characterized by a defect in insulin action. The hyperinsulinemic-euglycemic clamp, or insulin clamp, is widely considered the "gold standard" method for assessing insulin action in vivo. During an insulin clamp, hyperinsulinemia is achieved by a constant insulin infusion. Euglycemia is maintained via a concomitant glucose infusion at a variable rate. This variable glucose infusion rate (GIR) is determined by measuring blood glucose at brief intervals throughout the experiment and adjusting the GIR accordingly. The GIR is indicative of whole-body insulin action, as mice with enhanced insulin action require a greater GIR. The insulin clamp can incorporate administration of isotopic 2[C-14] deoxyglucose to assess tissue-specific glucose uptake and [3-H-3] glucose to assess the ability of insulin to suppress the rate of endogenous glucose appearance (endoRa), a marker of hepatic glucose production, and to stimulate the rate of whole-body glucose disappearance (Rd). The miniaturization of the insulin clamp for use in genetic mouse models of metabolic disease has led to significant advances in diabetes research. Methods for performing insulin clamps vary between laboratories. It is important to note that the manner in which an insulin clamp is performed can significantly affect the results obtained. We have published a comprehensive assessment of different approaches to performing insulin clamps in conscious mice(1) as well as an evaluation of the metabolic response of four commonly used inbred mouse strains using various clamp techniques(2). Here we present a protocol for performing insulin clamps on conscious, unrestrained mice developed by the Vanderbilt Mouse Metabolic Phenotyping Center (MMPC; URL: www.mc.vanderbilt.edu/mmpc). This includes a description of the method for implanting catheters used during the insulin clamp. The protocol employed by the Vanderbilt MMPC utilizes a unique two-catheter system(3). One catheter is inserted into the jugular vein for infusions. A second catheter is inserted into the carotid artery, which allows for blood sampling without the need to restrain or handle the mouse. This technique provides a significant advantage to the most common method for obtaining blood samples during insulin clamps which is to sample from the severed tip of the tail. Unlike this latter method, sampling from an arterial catheter is not stressful to the mouse(1). We also describe methods for using isotopic tracer infusions to assess tissue-specific insulin action. We also provide guidelines for the appropriate presentation of results obtained from insulin clamps.
引用
收藏
页数:9
相关论文
共 31 条
  • [11] Peroxisome proliferator-activated receptor-α deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet:: Hyperinsulinemic-euglycemic clamp studies
    Haluzik, M
    Gavrilova, O
    Leroith, D
    [J]. ENDOCRINOLOGY, 2004, 145 (04) : 1662 - 1667
  • [12] Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex - Relative roles of growth hormone and IGF-1 in insulin resistance
    Haluzik, M
    Yakar, S
    Gavrilova, O
    Setser, J
    Boisclair, Y
    LeRoith, D
    [J]. DIABETES, 2003, 52 (10) : 2483 - 2489
  • [13] Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-α agonist treatment is accompanied by paradoxical increase of circulating resistin levels
    Haluzik, M. M.
    Lacinova, Z.
    Dolinkova, M.
    Haluzikova, D.
    Housa, D.
    Horinek, A.
    Vernerova, Z.
    Kumstyrova, T.
    Haluzik, M.
    [J]. ENDOCRINOLOGY, 2006, 147 (09) : 4517 - 4524
  • [14] Counterregulatory deficits occur within 24 h of a single hypoglycemic episode in conscious, unrestrained, chronically cannulated mice
    Jacobson, L
    Ansari, T
    McGuinness, OP
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2006, 290 (04): : E678 - E684
  • [15] Glucocorticoid-deficient corticotropin-releasing hormone knockout mice maintain glucose requirements but not autonomic responses during repeated hypoglycemia
    Jacobson, Lauren
    Ansari, Tasneem
    Potts, Jessica
    McGuinness, Owen P.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2006, 291 (01): : E15 - E22
  • [16] Peroxisome proliferator-activated receptor-α agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis
    Kim, H
    Haluzik, M
    Asghar, Z
    Yau, D
    Joseph, JW
    Fernandez, AM
    Reitman, ML
    Yakar, S
    Stannard, B
    Heron-Milhavet, L
    Wheeler, MB
    LeRoith, D
    [J]. DIABETES, 2003, 52 (07) : 1770 - 1778
  • [17] Differential effects of interleukin-6 and-10 on skeletal muscle and liver insulin action in vivo
    Kim, HJ
    Higashimori, T
    Park, SY
    Choi, H
    Dong, JY
    Kim, YJ
    Noh, HL
    Cho, YR
    Cline, G
    Kim, YB
    Kim, JK
    [J]. DIABETES, 2004, 53 (04) : 1060 - 1067
  • [18] Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle
    Kim, JK
    Michael, MD
    Previs, SF
    Peroni, OD
    Mauvais-Jarvis, F
    Neschen, S
    Kahn, BB
    Kahn, CR
    Shulman, GI
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (12) : 1791 - 1797
  • [19] Adipocyte-specific overexpression of FOXC2 prevents diet-induced increases in intramuscular fatty aryl CoA and insulin resistance
    Kim, JK
    Kim, HJ
    Park, SY
    Cederberg, A
    Westergren, R
    Nilsson, D
    Higashimori, T
    Cho, YR
    Liu, ZX
    Dong, JY
    Cline, GW
    Enerback, S
    Gerald, GI
    [J]. DIABETES, 2005, 54 (06) : 1657 - 1663
  • [20] PKC-θ knockout mice are protected from fat-induced insulin resistance
    Kim, JK
    Fillmore, JJ
    Sunshine, MJ
    Albrecht, B
    Higashimori, T
    Kim, DW
    Liu, ZX
    Soos, TJ
    Cline, GW
    O'Brien, WR
    Littman, DR
    Shulman, GI
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (06) : 823 - 827